Applied DNA Schedules Fiscal 2018 First Quarter Financial Results Conference Call for Thursday, February 8, 2018 at 4:30 PM ET
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied
DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to
release financial results for its fiscal 2018 first quarter ended
December 31, 2017 after market close on Thursday, February 8, 2018. In
conjunction with the release, the Company has scheduled a conference
call at 4:30 p.m. Eastern Time that will also be broadcast live over the
internet.
What: |
Applied DNA’s Fiscal 2018 First Quarter Financial Results Conference Call |
When: |
Thursday, February 8, 2018, at 4:30 p.m. Eastern Time |
Where: |
Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask |
A telephonic replay of the conference call will be available for one day
and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with
the passcode 10115974. The webcast
will be archived in the Investors
section of the company’s website.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics. The
Company makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion.
The proprietary DNA-based CertainT® platform
can be used to identify, tag, test, and track products, to help assure
authenticity, origin, traceability, sustainability and quality of
products. SigNature® DNA describes the core technology ingredient that
is at the heart of a family of uncopyable, security and authentication
solutions such as SigNature®T and fiberTyping®, targeted towards
textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss
prevention, and digitalDNA®, providing powerful track-and-trace. All
provide a forensic chain of evidence, and can be used to prosecute
perpetrators. Applied DNA Sciences is also engaged in the large-scale
production of specific DNA sequences using the polymerase chain reaction.
Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.
Forward Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN’s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 28, 2017, which is available at www.sec.gov.
APDN undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
Contacts
Investors:
LHA Investor Relations
Sanjay M. Hurry,
212-838-3777
[email protected]
or
Web:
www.adnas.com
| twitter: @APDN